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Abstract: Cell motility is a critical aspect of several processes such as wound healing and immunity; however, it is

dysregulated in cancer. Current limitations of imaging tools make it difficult to study cell migration in vivo. To
overcome this, and to identify drivers from the microenvironment that regulate cell migration, bioengineers have
developed 2D and 3D tissue model systems in which to study cell motility in vitro, with the aim of mimicking

elements of the environments in which cells move in vivo. However, there has been no systematic study to
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explicitly relate and compare cell motility measurements between these geometries or systems. Here, we provide
such analysis on our own data, as well as across data in existing literature to understand whether, and which,
metrics are conserved across systems. To our surprise, only one metric of cell movement on 2D surfaces
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significantly and positively correlates with cell migration in 3D environments (percent migrating cells, and cell
invasion in 3D has a weak, negative correlation with glioblastoma invasion in vivo. Finally, to compare across

complex model systems, in vivo data, and data from different labs, we suggest that groups report an effect size, a
statistical tool that is most translatable across experiments and labs, when conducting experiments that affect
cellular motility.
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1. Introduction

Cell migration is the evolutionarily conserved ability of cells to move varying distances depending on both intrinsic
and extrinsic cues from their environment 1-3. Cell movement is vital for the development of complex, multicellular
organisms during development and organogenesis

4-7

. Several crucial processes important to homeostasis, such as

wound healing, inflammation, and angiogenesis, are dependent on cell migration 8-13. Just as cellular motility plays

a key role in normal development and function, its dysregulation has serious implications in pathobiology. Absent
motility of immune cells leads to serious autoimmune diseases, chronic inflammatory conditions, and delayed
wound healing

8,14-16

. Conversely, enhanced cell migration is a hallmark of cancer, with invasion of tumor cells

correlating with poor patient prognosis 17.

In order to best understand aspects of cellular motility, such as cell migration and cell invasion, we and others have

developed sophisticated and controllable in vitro systems

18-23

. For example, synthetic biomaterials designed to

mimic the extracellular matrix (ECM) allow us to conduct experiments to better understand cell movement in 3D
including interactions between cells and their ECM. These in vitro systems, coupled with live microscopy, have
allowed us to see cells move in response to extracellular signals and genetic manipulations that would be
impossible in vivo. These analyses have been reviewed most recently by Decaesteker et al. with the merits of each
This article is protected by copyright. All rights reserved.

system described in detail

24,25

. Importantly, the jump to 3D systems creates a more physiologically relevant

environment that now requires cells to not only feel and move around on surfaces, but to also squeeze, modify, and
manipulate the environment around them. In vivo measurements of invasion and cellular movement is difficult,
26,27

. However,
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though has become possible through the use of intravital imaging with fluorescently labeled cells

the use of 3D in vitro systems is still preferred not only due to the large cost associated with using animal models,
but also due to their controllability, ease of implementation, and flexibility.

There are many challenges in analyzing the data collected on cellular motility and invasion with biomaterial-based
systems. These include the diversity of assays, metrics, and analyses that result in difficulty in correlating results
across platforms, stimuli, and labs. Most of the metrics used to analyze cellular invasion and motility have been

developed in 2D and translated to 3D studies. We summarized the most commonly used metrics in Table 1, which
include both continual live microscopy and endpoint imaging. We found cell migration reported on a population
level, such as percent of cells invaded or migrating, or at a single cell level, such as migration speed or distance
traveled. In this commentary, we describe the interrelation between these different motility measurements, the
important differences in assays and reporting techniques used across the literature, and the potential predictive
nature of in vitro assays to in vivo outcomes in a single model system.

2. Results

Common metrics for tumor cell motility often interrelate with one another
To begin to understand how cellular motility metrics may interrelate, we analyzed the correlations between
outcomes for multiple glioma cell lines by calculating the Pearson’s Correlation Coefficient r, where 0.1≤ |r| <0.3
indicates weak correlation, 0.3≤ |r| < 0.5 indicates moderate correlation, and 0.5≤ |r| <1 indicates strong correlation.
We summarize them in Table 1, which include percent invading cells, percent migrating cells, chemotactic index,
speed, total, and net displacement. Excluding percent invasion, which is a chamber-based endpoint assay, all other
metrics mentioned are obtained from live, continuous microscopy. As a first case study, we compared live imaging
and percent invasion data for several patient-derived glioma stem cell (GSC) lines, including G2, G34, G62, and
G528 (Figure 1, Figure S1). We first compared motility metrics assessed with live imaging to endpoint percent
This article is protected by copyright. All rights reserved.

invasion and determined that no single metric significantly correlated with this endpoint metric (Figure 1a, p>0.05).
Although they are not statistically significant, there was a moderate correlation (0.3≤ |r| <0.5) for chemotactic index
(r=-0.446, p=0.199) and a strong correlation (0.5≤ |r| ≤1) for the speed (r=0.742, p=0.056). Next, we aimed to
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determine if there was a correlation between the percent of migrating cells in a total population and single cell
metrics of motility (Figure 1b) and identified that both total and net displacement positively correlated with the
total percent of cells that were migrating (r=0.707 and 0.711 respectively, p<0.05). Finally, we compared the single
cell metrics of motility based on tracts of individual cells to identify correlations both averaged for the total
population (Figure 1c) and of the single cells (Figure 1d, n=1182 cells tracked). We found an expected positive
correlation between net displacement and speed (Figure S1a, r>0.98, p<0.001), and between displacement and
chemotactic index for both the population averaged outcomes (Figure 1c) and the individual cell measurements
(Figure 1d). The correlations with percent invasion are particularly interesting as the invasion of cells in vitro is

often assumed to be predictive of invasiveness in vivo. Overall, these correlations indicate that it may be possible to
infer some cellular motility behaviors from a single assay/measurement. This may be important when making
decisions regarding experimental design and analysis of data.

For glioblastoma cell lines, 2D motility correlates with 3D motility
Although cellular motility in 2D and 3D microenvironments entail many of the same underlying mechanisms of
cellular motion including contractility, adhesion, and cytoskeletal rearrangement, 3D systems are thought to better
mimic in vivo conditions by surrounding cells with the ECM. Given the increased use of 3D environments in which
to study cells, we sought to evaluate what measurements of 2D motility might translate to cell migration in 3D.
Using glioma as a case study, we compared the 2D and 3D motility measurements (Figure 2) across experiments
with four glioma stem cell lines and one glioma cell line by calculating correlation coefficients (Pearson’s r) and p

values. Comparing percent migrating cells, speed, net distance, and chemotactic index in 2D vs 3D environments
showed that only one metric—percent of migrating cells—correlated significantly between 2D and 3D (Figure 2a,
r=0.878, p<0.001). Generally, the total percentage of cells migrating was significantly higher in 2D than in 3D, as
explained by a linear regression ([2D]=3.3×[3D]+21.2). Speed of cells migrating was also lower in 3D than in 2D,
as has been commonly reported

28-32

. Observationally, the range of chemotactic indices was strongly correlated,

This article is protected by copyright. All rights reserved.

though not statistically significant, between 2D and 3D (Figure 2c, r=0.948). When comparing the total and net
displacement in 3D compared to 2D culture, there were weak correlations in between as well as statistically not
significant. Thus, we were surprised to see that many metrics of individual cell motility did not correlate between
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2D and 3D, though the total percent of migrating cells did.

No obvious relationship between measurement time or cell density and cell migration quantification from
the literature
The data in Figures 1 and 2 are a result of experiments performed in a single lab, and thus, potential confounding
factors such as the culture medium, culture substrate, type and length of assay, and interpretation of data were
largely controlled for. However, across the literature, cellular motility is examined not only via different metrics
and assays, but also with varying experimental setup. Thus, we aimed to examine the variability in assay set up and
its potential effects on outcomes through a careful literature search focused on several of the most widely examined
cell lines in motility assays. We compiled data from a list of publications measuring motility in 2D and 3D
platforms (Figure 3 and Supp. Tables 1-6) among widely used cell lines to extrapolate our findings to that beyond

our own labs. We focused on studies of cell motility in 3D that reported % invasion (Figure 3a, b) and % migrating
(Figure 3c, d), and studies that reported % wound closure in 2D (Figure 3e). We saw no significant correlation for
the 3D motility outcomes with the two consistent experimental conditions reported (assay duration and cell
density). In the case of wound healing assays, however, there was an unsurprising correlation between assay
duration and percent of wound closure (r=0.87, p<0.01) (Figure 3c).

We found that biomaterial properties like pore size and composition were similar across studies, although
concentrations of basement membrane extract (i.e. Matrigel®) used were often not reported (Supp. Tables 1-2). Cell

invasion outcomes from tissue culture insert assays were reported differently across publications and included total
cell number, self-defined “invasion value,” fold change, percent invasion, or images without quantitative metrics
(Supp. Table 3). Assay readouts varied significantly between crystal violet, H&E staining, trypsinization prior to
counting, or simply imaging counting, all at different time points (Supp. Tables 3-5). In the case of invasion,
attractants used in invasion assays were unique to each study (Supp. Table 6). Thus, we could not determine a
This article is protected by copyright. All rights reserved.

correlation between the assay experimental setup and the cell migration-related outcomes. We were also unable to
quantitatively evaluate all experimental design components (such as matrix concentration) within this small sample
size of publications. Similarly, when examining live imaging data in Collagen I matrices, another popular substrate
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for tumor cell motility assays, we saw a high degree of variability in metrics measured across ten studies including
percent migrating and cell speed (Supp. Figure 4).

In vivo invasion in glioma negatively correlates with 3D chemotactic index

One major stated goal of in vitro assays is to predict, or at least model, cell movement in order to better understand
the mechanistic underpinnings and driving factor of cell movement in vivo. For glioblastoma (GBM), the deadliest
form of brain cancer, invasion is a hallmark of its behavior and is responsible for recurrence after treatment. Unlike
other cancers, in GBM, invasive cells remain within the primary organ, which allows for straightforward
quantification of invasion at an endpoint using immunohistochemistry. We hypothesized that this invasion would
positively correlate with outcomes of cellular motility in vitro. Using previously published data from five models of
GBM (our four glioma stem cell lines and the rat glioma line RT2) implanted into rodent cortex, we quantified cells
that had invaded beyond the tumor border and correlated these numbers to our assays in vitro (Figure 4a). Results
from at least four mice were averaged (data from 33) and plotted against averaged values from at least four in vitro
experiments. For cells in 3D, we did not see a statistically significant correlation between any motility metric in
vitro and our in vivo results (Figure 4b-g). However, we did see a moderate negative correlation for 3D chemotactic

index (Figure 4e) and strong negative correlations for both net and total displacement (Figure 4g) with in vivo
invasion. In 2D, we saw a strong positive, though not significant, correlation only when comparing percent
migrating cells (Figure S2a) with the invasion metric in vivo. Due to our low number of cell lines to compare in
vitro and in vivo, it is difficult to draw concrete conclusions about invasion in vitro and in vivo, though we see
interesting negative trends that are contrary to our current assumptions about translating in vitro invasion outcomes
to in vivo results. These data were generated from the same lab using a single biomaterial system and can thus be
analyzed together, but an ability to examine data across labs, tumor models, and in vitro models would allow us to
better interpret in vitro and in vivo correlations. For this, unified metrics are necessary so that we can easily
compare between studies within and between laboratories.
This article is protected by copyright. All rights reserved.

Effect size as a statistical tool to measure motility changes across dimensions
Mechanistic invasion and motility assays aim to determine the response to particular stimuli or inhibitor (and
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determine if that difference is statistically significant from some internal control). It is often assumed, though not
directly tested, that if a stimulus increases 2D motility it will do the same in 3D. To test this assumption, we
revisited our previous data and calculated effect sizes (Cohen’s d) in 2D and 3D to determine if 1) dimensionality
alters the effect of stimuli and 2) we can use effect size to better analyze and compare cell motility in response to
stimuli across dimensions. Unlike the r and p values we have used above to compare correlations between two
different cell motility metrics, here we used effect sizes to quantify and compare the size of the difference between
two groups. Effect size is a statistical concept that defines the strength of a relationship between two variables or
conditions on the same numeric scale 34. Effect size uses Cohen’s d value as an indicator, with Cohen’s d defined as
the difference between two means divided by the standard deviation. Cohen et al. states that when the Cohen’s d is

lower than 0.2, there is no effect. If the value is 0.2≤ |d| <0.5, there is a “small” effect, a “medium” effect if the
value is 0.5≤ |d| <0.8, and a “large” effect when |d| ≥0.8 (Figure 5a). Thus, using this value, one can easily compare
the effect of one treatment to another regardless of laboratory, experimental setup, or outcome measure to
determine how universal findings are.

Glioma motility in response to CXCL12. We examined motility of multiple patient-derived glioma stem cell lines in
the presence of 100nM of CXCL12 in 2D and 3D (Figure 5b) by reanalyzing our previously published data

33

.

CXCL12 is a pro-migratory chemokine that has been implicated in glioma motility and invasion 35. We quantified
multiple outcomes with live cell tracking and found that the effect size varied based on the dimensionality. For
some cell lines (G62) the effect size was nearly equal for percent motile cells when cells were stimulated in 2D or
3D and indicated that there was a small effect (<0.2) of the stimulation. For G2 and G528, the effect size varied but
remained large (≥0.8) for both cell lines in both dimensions. Interestingly though, for G34, the effect in 2D was
medium, but large in 3D, indicating that dimensionality may affect this cell line-specific response to CXCL12.

This article is protected by copyright. All rights reserved.

Breast cancer motility in response to EGF and integrin inhibitors. To broaden the utility of effect size beyond
glioma to breast cancer cell behavior, Figure 5c shows SkBr3 cells that were seeded on a bone-ECM functionalized
surface and stimulated with epidermal growth factor (EGF) or inhibitors for integrin subunits β1 and α2

36

. EGF
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stimulation ultimately leads to cell proliferation, and integrins are necessary for cell-ECM binding, cell migration,
and invasion. The original study used Spearman correlation and p values to validate correlations among different
cell motility metrics 36; however, it did not allow as to compare the effect of each stimuli or inhibition on 2D vs. in
3D. EGF stimulation had a small effect, and β1 integrin inhibition had a medium effect, in both 2D and 3D. In
addition, α2 integrin inhibition had a large effect on 2D, but a medium effect in 3D. Our analysis highlights the
utility of using the statistical tool effect size to determine its importance given its ability to span dimensionality and
cell sources.

3. Discussion

In this analysis, we found that the diversity of invasion and motility assay measurement approaches, reporting
tools, and responses all vary across labs (Figure 3 and Supp. Tables 1-6). Though motility metrics have been
studied in multiple contexts for decades, there is still not a consensus nor clarity in terms of the importance of each
and the impact of each on outcomes in vivo. In cancer, this is particularly striking as there is already a high level of
heterogeneity in the disease itself, which is amplified as we move into complex in vitro models. One major
impediment to the field’s progress is the variability from lab to lab in the implementation and analysis of these
experiments. First, we identified high variability in the assay setup. As illustrated in Supplemental Table 1,
concentrations of Matrigel® used for invasion assays differed, and in some publications, were not reported. We
know that the source and the lot of basement membrane extracts (like Matrigel®) can influence experiments alone,

let alone the concentration 37. Similarly, assay durations and cell densities differed across most publications using
breast cancer cell lines (Supp. Tables 3-5). Unsurprisingly, the assay duration correlated positively with degree of
wound closure (Figure 3e). When we looked through how different publications quantified their assay outcomes,
we noticed variable methods to count invasive cells from the bottoms of tissue culture inserts, including selection
of immunocytological stain and/or fixation vs. cellular detachment and counting. Regardless, publications generally
reported some final number, though this could be a percent, fold change, or total number of cells that prevented us
This article is protected by copyright. All rights reserved.

from directly comparing their results as were able to do for our own experiments. A standardized metric that best
conveys the raw data would allow to compare outcomes in a meaningful way across labs.
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We propose effect size as a useful metric to understand how and if stimuli and inhibitors affect cell motility across
geometries and labs. For example, as seen on Figure 5b and 5c, comparing each Cohen's d value illustrates the
effect of each ECM substrate or each stimulus for two different cell types. Within each cell line, we can see the
significant effect of the stimulus on cell response, across geometries, and independent of the cell’s genetic

background. Additionally, comparing the value of the effect size (≥0.2, ≥0.5, or ≥0.8) allows us to better
understand how large an effect is, without the need for a p-value (which has been recently put into question 38). Not

only does it allow us to characterize two effect sizes in the same category, but it also gives us a better
understanding on whether there are large differences or not. For example, if the effect size is <0.2, it means the two
comparing group’s means do not differ by 0.2 standard deviations or more, which indicates the difference is small
even if it might be statistically significant. In this way, the effect size allows us to better quantify the real effect of a
stimulus on an experimental group compared to control, independent of a p-value.

The desire to understand how 2D cell migration relates to that in 3D is not unique to our study. Meyer et al.
quantified breast cancer cell line motility and showed that the degree of initial cell protrusion in 2D was predictive
of 3D invasion across many different stimuli 39. In agreement with or analysis of glioma cells, Meyer et al. found
no other obvious correlations between 2D and 3D cell migration measurements. Similarly, when studying the role
of focal adhesion proteins in cellular motility, Fraley et al. compared speed, persistence, protrusion
length/number/time, etc. in 2D and 3D and found no correlation between any of the metrics in the two
environments

40

. Next generation biomaterials are being developed that provide possible explanations of the key

differences between 3D and 2D environments that drive the unique motility phenotypes, such as confinement

41,42

and porosity 28.

Many labs are quantifying cell invasion in vivo in order to potentially discover druggable targets to halt malignant
cells from invading and metastasizing. 3D microenvironments have been lauded as “more physiologically
This article is protected by copyright. All rights reserved.

relevant”, but in our limited dataset we show that there is no significant correlation (slight negative trend) between
most motility metrics in 3D collagen/hyaluronan gels and invasion in vivo. Live imaging data in vivo may reveal
more information, but with at least this endpoint assay, we cannot predict in vivo “invasiveness” with in vitro
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invasion in glioma. This result is not altogether unsurprising in that the movement between dimensions and into a
more complex system includes many changes to biophysical interactions. Thus, it is possible that our in vitro
systems, even in 3D, do not have enough complexity to capture true in vivo behavior, such as additional cell-to-cell

interactions, growth factors, cytokines, and specific integrin binding sites to the ECM. Further, it may be that we
may never fully predict specific behaviors that translate in vivo, yet the information that we gain is still valuable for
fundamental understanding of cell motility.

Taken together, standardized metrics are needed that allow for direct comparison between 2D, 3D, and in vivo
models. Effect size can allow us to better compare the effects of different stimuli on motility metrics and perhaps
draw conclusions independent of dimension and environment. Given the rise of more physiological in vitro models

that result in more complicated responses, this could be a first step to implement comparison of metrics across the
field. Finally, standardizing motility metric outcomes could help bridge the gap between 2D, 3D in vitro systems
and their translation to in vivo physiology.

4. Materials and Methods

Cell culture
All cell culture supplies were purchased from Thermo Fisher Scientific (Waltham, MA) unless otherwise noted.
The SkBr3 cell line was purchased from ATCC (Manassas, VA), and cells were grown in DMEM, supplemented
with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (pen/strep).

Preparation of ECMs for SkBr3 migration experiments
Glass coverslips (15 mm and 18 mm diameter, Fisher Scientific, Agawam, MA, USA) were functionalized with 10
g/L N,N-disuccinimidyl carbonate (Sigma-Aldrich) and 5% v/v diisopropylethylamine (Sigma-Aldrich), and ECM
protein cocktails were then covalently bound to the glass coverslips through reactive amines: 5 μg/cm 2 of 99%
This article is protected by copyright. All rights reserved.

collagen I and 1% osteopontin

36

. Coverslips were incubated with proteins at room temperature for three hours,

rinsed three times with PBS, and then incubated with 10 μg/cm2 MA(PEG)24 (Thermo Scientific, Rockford, IL,
USA) for two hours. Coverslips were rinsed three times with PBS, epoxied to the plate (Devcon 5 minute epoxy)
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and UV-sterilized prior to cell seeding. For invasion studies from coverslips, cells were seeded on coverslips and
then overlaid with a collagen gel as previous described 36.

3D Invasion Assays Analysis
Invasion assay data for glioma cells was acquired from our previous publications where it was conducted as
described

33,43

. Membranes were imaged at five non-overlapping locations and % invasion was calculated as an

extrapolated cell count divided by the seeded cell count × 100. Data included in this publication was taken from our
previous publications for RT2, G2, G34, G62, G528 33,43.

Live Imaging Analysis
Glioma Motility: The motility metrics were determined via live imaging and single-cell tracking of glioma cells
from previously acquired and published images. Images taken in 20-minute intervals for 18-24 hours were analyzed
for cell motility metrics. The manual tracking feature on Celleste 4.1 was used to record the location of the visually
identified center of the cell of interest in each image of the sequence. An average of 15 cells were tracked per
image. The recorded X and Y coordinates were analyzed in Matlab 2018b with the following outcomes: average
speed, net and total displacements, and chemotactic index of each cell. Two to nine image sequences were analyzed
per cell type (G528, G62, G34, and G2 33) and experimental condition (2D, 3D) combination per experiment. The
averaged values per experiment are reported here. Data for RT2 was taken from previous publication 43.

SkBr3 Motility: Cells were seeded at 4,000 cells/cm2 on ECM protein treated surfaces. They were then treated with
a live-cell fluorescent dye (CMFDA, Life Technologies), and fresh medium or medium supplemented with EGF
and/or integrin antibodies were provided 4 hours prior to microscopy. Brightfield and fluorescent images were
taken at 15-minute intervals for 12 hours using an EC Plan-Neofluar 10x 0.3 NA air objective (Carl Zeiss). Cells
were tracked using Imaris (Bitplane, St. Paul, MN, USA) to generate individual cell paths, and individual cell
This article is protected by copyright. All rights reserved.

speeds were determined by calculating a speed at every 15-minute time interval, then averaging these over the
entire 12 hours.
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Tumor Inoculation
Tumor images from previous publications were reanalyzed to determine the number of cells migrated per area
beyond the tumor border. Original experiments were approved by Institutional Animal Care and Use Committees
as described in those publications. After importing raw images into ImageJ, cells were counted in four to five 0.49
mm2 regions of the image. RT2 glioma cell line in rat 44; G2, G34, G528 glioma stem cells in SCID mice 33; and
G62 glioma stem cell in SCID mice 45.

Invasion calculations from published data
Percent of invasion, and migration data were extracted with the WebPlotDigitizer v4.1 from the published work
cited in Figure 3 and Supplementary Tables 1-6. Re-plotted data was used to calculate the percent of invasion based
on the initial number of seeded cells.

Effect size calculations

Effect size measures were performed between two independent groups following Cohen’s d calculation:
𝒅 = 𝑴𝟏 − 𝑴𝟐 /𝒔𝒑𝒐𝒐𝒍𝒆𝒅
𝒔𝒑𝒐𝒐𝒍𝒆𝒅 = √(𝒔𝟐𝟏 + 𝒔𝟐𝟐 )/𝟐

Here, M1 and M2 are the means of two independent samples being compared (e.g. control vs. experimental group),
and Spooled is the pooled standard deviation where s1 and s2 are the standard deviations of the groups 1 and 2,
respectively. We used the online calculator from Dr. Lee A. Becker at the University of Colorado, Colorado
Springs at https://www.uccs.edu/lbecker/

5. Conclusion

This article is protected by copyright. All rights reserved.

Current challenges in the field of cellular motility and invasion within biomaterial-based systems, including
diversity of assays, metrics, and analyses, limit the translation of results across platforms and impede correlation
between 2D, 3D and in vivo. Here, we summarize the most commonly used metrics to quantify cell motility, and
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describe the interrelation between these different motility measurements, the important differences in assays and
reporting techniques used across the literature, and describe the potential contribution of in vitro predictions to in

vivo outcomes. To our surprise, we found cell invasion in 3D has a weak negative correlation with invasion in a
glioblastoma model in vivo. Given the variability we saw in reporting in the literature, and the inability to predict

3D or in vivo invasion from simpler 2D assays, we suggest that standardized metrics are needed. We recommend
the use of effect size as a possible avenue that allows direct comparison between two different groups independent
on dimensionality or stimulus. Given the rise of more physiological in vitro models that result in more complicated

responses, this could be a first step to implement comparison of metrics across the field. Finally, standardizing
motility metric outcomes could help bridge the gap between 2D, 3D in vitro systems and their translation to in vivo
physiology.

This article is protected by copyright. All rights reserved.
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Figure and Table Legends
Table 1. Common metrics used in the literature to determine tumor cell motility
Figure 1. Correlations of motility outcomes for individual cell lines A) Metrics of motility
determined by live imaging analysis and tracking vs. % Invasion as determined in a tissue culture
insert assay. B) Individual cell motility outcomes vs. overall % of migrating cells as measured
using live imaging and tracking. C) Individual cell motility metrics averaged by cell line and
dimension with D) Single cell data. Pearson r correlation with p values listed on each graph.
Figure 2. Motility metrics compared in 2D and 3D environments for glioma cells Averaged
motility outcomes determined from live imaging and tracking are shown for individual
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experimental runs and correlated by glioma cell line. a) Percent of cells migrating greater than
two cell lengths. b) Speed of cells c) Chemotactic index d) Net displacement and e) Total
displacement as determined from individual tracks. Pearson r correlation with p values listed on
each graph.
Figure 3. Correlation of experimental set up and outcomes from literature for tumor cells.
Compiled data outcomes from existing experiments in the literature that examine tumor cell
motility as compared to assay parameters. a) Percent invasion in a tissue culture insert-Matrigel
assay vs. duration of the experiment and b) initial cell seeding density. c) Percent of cells
migrating through tissue culture inserts (without Matrigel) vs. the duration of the experiment and
d) initial cell seeding density. e) Percent of wound closure in traditional 2D scratch assay vs the
duration of the experiment. Pearson r correlation with p values listed on each graph.
Figure 4. Motility metrics compared in a 3D environment in vitro to in vivo. a) From left to right
the images represent the in vitro invasion assay, live imaging micrograph from cells in a 3D
hyaluronan matrix in vitro and glioma cells implanted in mouse brain at the tumor border with
invasive cells beyond the border (arrowheads). b) In vitro percent invasion c) Percent cells
migrating, d) Speed, e) Chemotactic Index, f) Total Displacement, and g) Net displacement
graphed by glioma cell line vs. the number of invaded cells beyond the tumor border in vivo per
mm2 of tissue. Pearson r correlation with p values listed on each graph.
Figure 5. Motility effect sizes for tumor cells in 2D or 3D. a) Cohen’s d (effect size) delineations
for small (≥0.2, <0.5), medium (≥0.5, <0.8) and large (≥0.8) effect sizes. b) Cohen’s d calculated
for percent migrating cells when stimulated with CXCL12 vs. vehicle control of patient-derived
glioma stem cell lines in 2D and 3D. c) Cohen’s d for SkBr3 breast cancer cells when stimulated
with epidermal growth factor or treated with inhibitors of Integrin-β1 or Integrin-α2 in 2D (for
speed of cell migration) or 3D (for invasion into collagen gels).
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